I don't know how you read that into what I wrote.

It doesn't have to be perfectly safe; but it has to be significantly safer if you get it, than the disease if you get it -- which is, in fact, the case for all regularly administered vaccines (MMR, polio, tetanus, etc.), and comes with a warning and explanation for those that aren't (our pediatrician made sure we understand the rotavirus vaccine before we gave it to our child (we did) especially because it's safety profile, while still good, is not as good as the MMR and polio ones.

MIS-C is a big discussion that I don't have enough time for, but according to https://www.cidrap.umn.edu/news-perspective/2021/04/new-find..., incidence in the US is 1:50,000. Acute myocarditis often goes away with no damage but not always. MIS-C does too.

And it's not even clear yet if any vaccine will stop MIS-C, so -- no, it's not an entirely acceptable risk.

The MIS-C rate is 1-in-12,500 per the CDC:

https://www.cdc.gov/mmwr/volumes/69/wr/mm6932e3.htm?s_cid=mm...

1-in-3 hospitalizations require admittance to the ICU.

The study you cite is total incidence.

I was referring to total incidence, because approved vaccines have total incidence (Israel, where I now reside, has >84% of eligible population already vaccinated), so that's what you should compare to when considering vaccine adverse events vs. disease adverse events.

But something doesn't compute;

1:12,500 COVID incidence vs. 1:50,000 total incidence means 1 in 4 kids in the US has confirmed covid, despite less than 10% of the US population being verified (32.4M as of this second).

If we extrapolate the 1:12,500 number to the whole population (assuming 10% of the kids are confirmed), it's 1:125,000 for MIS-C in disease, vs. 1:20,000 myocarditis with vaccine. I'm not sure it's valid extrapolation (and I suspect your data, from July, is very outdated), either way -- it is not possible, based on this data, to claim that it is clearly beneficial to vaccinate children.

The data I'm familiar with DOES show that at age > 50 there are clear benefits. But, especially with respect to things like age, obesity and other attributes, it is very far from "one size fits all".

Only 1 out of 3-4 infections are confirmed. That would increase the actual number of infections to 30%-40% which is in-line with having at least 1 in 4 children having been infected.

Current total incidence is the wrong metric to use since tht will increase over time. Not using vaccines would mean 3x or so more infections before some level of herd immunity was reached.

It would also give the virus another 3x the number of die rolls towards mutating as well, with pressure to increase transmissibility which should come with an increase in virulence.

And my 1-in-12,500 numbers were before the virus started to mutate to increase transmissibility/virulence. Those numbers will probably drop.

I don’t have time now to check this, but most research I know shows mutations happen significantly more often in the immune compromised even when vaccinated on one hand, and that while increased transmissibility is associated with a strain or too, that’s not remotely true in general or about virulence.

Regardless, if I take your numbers, assuming 33% had the virus, we’re talking about very similar toys incidence at saturation (the 1:20,000 - 1:10,000 range, the error bars are huge), so it is far from obvious that the existing vaccines are safer than the disease.

It is true for all approved vaccines I’m familiar with; but you can’t claim that for any of the Sarscov2 vaccines based on available data.

What I’m really surprised is that somehow the default mindset changed from “we have to establish safety to use” to “we have to establish non-safety to not use”. Am really puzzled by that.